Real-World Clinical Characteristics and Treatment Patterns Among Patients with Unresectable Hepatocellular Carcinoma Amenable to Locoregional Therapy in the United States
Changing Treatment Paradigms and Unmet Needs in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Metastatic Breast Cancer (mBC): Results from Health Records Data
Real-World Treatment Patterns and Clinical Outcomes for Patients with Metastatic Triple-Negative Breast Cancer (mTNBC) in the United States: an Electronic Health Records Observational Study
Evolving Treatment Paradigms and Unmet Needs in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2-), PIK3CA-Mutated Metastatic Breast Cancer (mBC): Results from Real-World U.S. Health Records Data
Real-World Clinical Practice PIK3CA Biomarker Testing Patterns in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2-) Metastatic Breast Cancer (mBC)
Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations
A Retrospective Real-World Evaluation of Docetaxel-Based Treatments After Standard of Care (SOC) for Patients with Nonsquamous (NSQ) Advanced Non-Small Cell Lung Cancer (aNSCLC)
Epidemiology of Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer in the U.S., 2011─2022: A Retrospective Observational Study
Real-World Tumor BRCA Testing Patterns and PARP Inhibitor Use in HER2-Negative Metastatic Breast Cancer